Probability of survival in patients who underwent T cell–replete NIMA-complementary stem cell transplantation. Kaplan-Meier estimates of overall survival in 35 patients who underwent HLA-haploidentical SCT from a microchimeric NIMA-mismatched donor for advanced hematologic malignancies. (A) All patients; (B) comparison according to disease status at transplantation (P = .17 by log-rank test).